Axogen, Inc. (AXGN) News
Filter AXGN News Items
AXGN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AXGN News Highlights
- AXGN's 30 day story count now stands at 4.
- Over the past 8 days, the trend for AXGN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about AXGN are META.
Latest AXGN News From Around the Web
Below are the latest news stories about AXOGEN INC that investors may wish to consider to help them evaluate AXGN as an investment opportunity.
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022ALACHUA, Fla. and TAMPA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2022 revenue. Preliminary Unaudited Fourth Quarter and Year-End Performance and Business Highlights Fourth quarter revenue is expected to be approximately $36.1 million, a 16% increase compared to fourth-quarter 2021 excluding the imp |
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and ConduitsStudy concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including over 1,500 nerve repairs across 35 studiesALACHUA, Fla. and TAMPA, Fla., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the independent publication of a comprehen |
Axogen to Participate at J.P. Morgan 41st Annual Healthcare ConferenceALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, chairman, CEO, and president, will present at the JP Morgan 41st Annual Healthcare Conference in San Francisco. The presentation is scheduled for Thursday, January 12, 2023 at 9:45 a.m. PST (12:45 p.m. EST). The presentation will be webcast live and accessible thro |
AxoGen, Inc. (NASDAQ:AXGN) is favoured by institutional owners who hold 65% of the companyEvery investor in AxoGen, Inc. ( NASDAQ:AXGN ) should be aware of the most powerful shareholder groups. And the group... |
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donationALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation ® patient, has been selected to ride on the 2023 Donate Life Rose Parade Float and Madelyn Nicpon will be honored at this year’s event through a floragraph that will adorn the float. The Tournament of Roses ® parade takes place on January 2, 2023 in Pasadena. This is the tenth year Axogen has co-sponsored the Donate Life float to help raise awareness for the importance of organ and tissue donation. |
Axogen Patient to Ride the 2023 Donate Life Rose Parade Float Supporting awareness of organ and tissue donationALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation patient, has been selected to ride on the 2023 Donate Life Rose Parade Float and Madelyn Nicpon will be honored at this year’s event through a floragraph |
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donationALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation® patient, has been selected to ride on the 2023 Donate Life Rose Parade Float and Madelyn Nicpon will be honored at this year’s event through a floragraph that will adorn the float. The Tournament of Roses® parade takes place on January 2, 2023 in Pasad |
AxoGen Stock: Rally Potentially Exhausted, Revise To Hold (NASDAQ:AXGN)We believe there may be downside risk in AxoGen looking ahead. Read more to see why we think AXGN''s rally may have exhausted and why we''re revising our rating. |
How did AxoGen Inc. (AXGN) fare last session?The share price of AxoGen Inc. (NASDAQ:AXGN) rose to $10.95 per share on Wednesday from $10.48. While AxoGen Inc. has overperformed by 4.48%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AXGN rose by 14.42%, with highs and lows ranging from $13.66 to $6.87, whereas the […] |
Here's Why "Trend" Investors Would Love Betting on AxoGen (AXGN)If you are looking for stocks that are well positioned to maintain their recent uptrend, AxoGen (AXGN) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. |